CRL Annual SG&A
$747.86 M
+$82.76 M+12.44%
30 December 2023
Summary:
As of January 21, 2025, CRL annual selling, general & administrative expenses is $747.86 million, with the most recent change of +$82.76 million (+12.44%) on December 30, 2023. During the last 3 years, it has risen by +$218.92 million (+41.39%). CRL annual SG&A is now at all-time high.CRL Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly SG&A
$199.21 M
+$29.42 M+17.33%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly selling, general & administrative expenses is $199.21 million, with the most recent change of +$29.42 million (+17.33%) on September 28, 2024. Over the past year, it has increased by +$2.07 million (+1.05%). CRL quarterly SG&A is now -0.27% below its all-time high of $199.76 million, reached on June 1, 2023.CRL Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM SG&A
$8.02 B
+$402.39 M+5.28%
28 September 2024
Summary:
As of January 21, 2025, CRL TTM selling, general & administrative expenses is $8.02 billion, with the most recent change of +$402.39 million (+5.28%) on September 28, 2024. Over the past year, it has increased by +$7.28 billion (+972.85%). CRL TTM SG&A is now at all-time high.CRL TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.4% | +1.1% | +972.9% |
| 3 y3 years | +41.4% | +1.1% | +972.9% |
| 5 y5 years | +68.5% | +1.1% | +972.9% |
CRL Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.6% | -0.3% | +51.3% | at high | +141.5% |
| 5 y | 5-year | at high | +44.5% | -0.3% | +56.0% | at high | +995.7% |
| alltime | all time | at high | +2090.4% | -0.3% | +1690.8% | at high | +477.9% |
Charles River Laboratories International Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $199.21 M(+17.3%) | $752.44 M(+3.2%) |
| June 2024 | - | $169.79 M(-8.9%) | $729.33 M(-3.9%) |
| Mar 2024 | - | $186.29 M(-5.5%) | $759.30 M(+1.5%) |
| Dec 2023 | $747.86 M(+12.4%) | $197.14 M(+11.9%) | $747.86 M(-0.3%) |
| Sept 2023 | - | $176.11 M(-11.8%) | $750.35 M(-1.0%) |
| June 2023 | - | $199.76 M(+14.2%) | $757.96 M(+9.9%) |
| Mar 2023 | - | $174.85 M(-12.4%) | $689.91 M(+3.7%) |
| Dec 2022 | $665.10 M(+7.3%) | $199.64 M(+8.7%) | $665.10 M(+9.1%) |
| Sept 2022 | - | $183.71 M(+39.5%) | $609.57 M(+6.1%) |
| June 2022 | - | $131.71 M(-12.2%) | $574.43 M(-6.5%) |
| Mar 2022 | - | $150.03 M(+4.1%) | $614.22 M(-0.9%) |
| Dec 2021 | $619.92 M(+17.2%) | $144.11 M(-3.0%) | $619.92 M(+0.2%) |
| Sept 2021 | - | $148.57 M(-13.4%) | $618.84 M(+3.4%) |
| June 2021 | - | $171.50 M(+10.1%) | $598.56 M(+7.9%) |
| Mar 2021 | - | $155.73 M(+8.9%) | $554.77 M(+4.9%) |
| Dec 2020 | $528.93 M(+2.2%) | $143.03 M(+11.5%) | $528.93 M(+2.6%) |
| Sept 2020 | - | $128.29 M(+0.5%) | $515.50 M(-0.2%) |
| June 2020 | - | $127.71 M(-1.7%) | $516.72 M(-1.6%) |
| Mar 2020 | - | $129.90 M(+0.2%) | $524.95 M(+1.4%) |
| Dec 2019 | $517.62 M(+16.6%) | $129.60 M(+0.1%) | $517.62 M(+4.6%) |
| Sept 2019 | - | $129.51 M(-4.7%) | $494.94 M(+3.4%) |
| June 2019 | - | $135.94 M(+10.9%) | $478.47 M(+3.3%) |
| Mar 2019 | - | $122.57 M(+14.6%) | $463.06 M(+4.3%) |
| Dec 2018 | $443.85 M(+19.6%) | $106.92 M(-5.4%) | $443.85 M(+3.0%) |
| Sept 2018 | - | $113.03 M(-6.2%) | $431.05 M(+5.0%) |
| June 2018 | - | $120.53 M(+16.6%) | $410.44 M(+7.0%) |
| Mar 2018 | - | $103.37 M(+9.8%) | $383.73 M(+3.4%) |
| Dec 2017 | $371.27 M(+1.8%) | $94.11 M(+1.8%) | $371.27 M(-0.4%) |
| Sept 2017 | - | $92.43 M(-1.5%) | $372.80 M(+1.9%) |
| June 2017 | - | $93.82 M(+3.2%) | $366.02 M(-1.8%) |
| Mar 2017 | - | $90.91 M(-4.9%) | $372.67 M(+2.2%) |
| Dec 2016 | $364.71 M(+21.4%) | $95.64 M(+11.7%) | $364.71 M(+4.0%) |
| Sept 2016 | - | $85.65 M(-14.8%) | $350.53 M(+2.8%) |
| June 2016 | - | $100.47 M(+21.1%) | $341.10 M(+9.3%) |
| Mar 2016 | - | $82.94 M(+1.8%) | $311.96 M(+3.8%) |
| Dec 2015 | $300.41 M(+11.7%) | $81.46 M(+6.9%) | $300.41 M(+3.2%) |
| Sept 2015 | - | $76.22 M(+6.9%) | $290.99 M(+4.2%) |
| June 2015 | - | $71.33 M(-0.1%) | $279.24 M(+1.3%) |
| Mar 2015 | - | $71.40 M(-0.9%) | $275.66 M(+2.5%) |
| Dec 2014 | $269.03 M(+19.2%) | $72.03 M(+11.7%) | $269.03 M(+5.2%) |
| Sept 2014 | - | $64.48 M(-4.8%) | $255.67 M(+3.9%) |
| June 2014 | - | $67.76 M(+4.6%) | $246.10 M(+5.5%) |
| Mar 2014 | - | $64.77 M(+10.4%) | $233.26 M(+3.4%) |
| Dec 2013 | $225.69 M(+8.4%) | $58.67 M(+6.9%) | $225.69 M(+3.4%) |
| Sept 2013 | - | $54.90 M(-0.0%) | $218.34 M(+1.8%) |
| June 2013 | - | $54.92 M(-4.0%) | $214.49 M(+2.4%) |
| Mar 2013 | - | $57.20 M(+11.4%) | $209.47 M(+0.6%) |
| Dec 2012 | $208.25 M | $51.32 M(+0.5%) | $208.25 M(+2.6%) |
| Sept 2012 | - | $51.05 M(+2.3%) | $203.01 M(+0.3%) |
| June 2012 | - | $49.90 M(-10.9%) | $202.31 M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $55.98 M(+21.5%) | $199.62 M(+0.5%) |
| Dec 2011 | $198.65 M(-14.6%) | $46.09 M(-8.5%) | $198.65 M(+11.3%) |
| Sept 2011 | - | $50.34 M(+6.6%) | $178.49 M(-13.4%) |
| June 2011 | - | $47.21 M(-14.2%) | $206.15 M(-8.0%) |
| Mar 2011 | - | $55.01 M(+112.2%) | $224.18 M(-3.2%) |
| Dec 2010 | $232.49 M(+2.1%) | $25.93 M(-66.8%) | $231.50 M(-11.1%) |
| Sept 2010 | - | $78.00 M(+19.6%) | $260.35 M(+10.1%) |
| June 2010 | - | $65.24 M(+4.7%) | $236.47 M(+3.8%) |
| Mar 2010 | - | $62.33 M(+13.8%) | $227.82 M(+0.1%) |
| Dec 2009 | $227.66 M(-1.1%) | $54.77 M(+1.2%) | $227.66 M(-0.2%) |
| Sept 2009 | - | $54.13 M(-4.3%) | $228.16 M(-0.2%) |
| June 2009 | - | $56.58 M(-9.0%) | $228.52 M(-1.9%) |
| Mar 2009 | - | $62.18 M(+12.5%) | $233.02 M(+1.2%) |
| Dec 2008 | $230.16 M(+5.8%) | $55.27 M(+1.4%) | $230.16 M(-0.5%) |
| Sept 2008 | - | $54.49 M(-10.8%) | $231.42 M(+1.2%) |
| June 2008 | - | $61.08 M(+3.0%) | $228.78 M(+2.2%) |
| Mar 2008 | - | $59.32 M(+4.9%) | $223.79 M(+2.9%) |
| Dec 2007 | $217.49 M(+20.3%) | $56.53 M(+9.0%) | $217.49 M(+4.7%) |
| Sept 2007 | - | $51.85 M(-7.6%) | $207.78 M(+5.4%) |
| June 2007 | - | $56.09 M(+5.8%) | $197.14 M(+3.2%) |
| Mar 2007 | - | $53.02 M(+13.2%) | $191.08 M(+5.7%) |
| Dec 2006 | $180.79 M(+14.4%) | $46.82 M(+13.6%) | $180.79 M(+15.5%) |
| Sept 2006 | - | $41.21 M(-17.6%) | $156.53 M(-1.1%) |
| June 2006 | - | $50.03 M(+17.1%) | $158.30 M(+6.0%) |
| Mar 2006 | - | $42.73 M(+89.5%) | $149.34 M(-1.4%) |
| Dec 2005 | $158.00 M(+35.2%) | $22.55 M(-47.5%) | $151.45 M(-7.4%) |
| Sept 2005 | - | $42.98 M(+4.6%) | $163.62 M(+12.5%) |
| June 2005 | - | $41.07 M(-8.4%) | $145.46 M(+8.9%) |
| Mar 2005 | - | $44.85 M(+29.2%) | $133.61 M(+14.3%) |
| Dec 2004 | $116.88 M(+29.5%) | $34.72 M(+39.9%) | $116.88 M(+10.4%) |
| Sept 2004 | - | $24.82 M(-15.1%) | $105.91 M(+3.7%) |
| June 2004 | - | $29.22 M(+3.9%) | $102.09 M(+6.1%) |
| Mar 2004 | - | $28.12 M(+18.4%) | $96.22 M(+5.8%) |
| Dec 2003 | $90.24 M(+8.3%) | $23.75 M(+13.1%) | $90.98 M(+3.1%) |
| Sept 2003 | - | $21.00 M(-10.0%) | $88.21 M(+1.1%) |
| June 2003 | - | $23.35 M(+2.0%) | $87.23 M(+2.3%) |
| Mar 2003 | - | $22.89 M(+9.1%) | $85.27 M(+2.4%) |
| Dec 2002 | $83.30 M(+21.9%) | $20.97 M(+4.7%) | $83.30 M(+3.0%) |
| Sept 2002 | - | $20.02 M(-6.4%) | $80.88 M(+3.9%) |
| June 2002 | - | $21.39 M(+2.2%) | $77.88 M(+5.6%) |
| Mar 2002 | - | $20.92 M(+12.7%) | $73.77 M(+8.0%) |
| Dec 2001 | $68.31 M(+33.4%) | $18.55 M(+9.0%) | $68.31 M(+4.1%) |
| Sept 2001 | - | $17.02 M(-1.6%) | $65.60 M(+9.9%) |
| June 2001 | - | $17.29 M(+11.8%) | $59.71 M(+8.9%) |
| Mar 2001 | - | $15.46 M(-2.4%) | $54.85 M(+7.1%) |
| Dec 2000 | $51.20 M(+28.8%) | $15.84 M(+42.4%) | $51.20 M(+44.8%) |
| Sept 2000 | - | $11.12 M(-10.5%) | $35.36 M(+45.9%) |
| June 2000 | - | $12.43 M(+5.2%) | $24.24 M(+105.2%) |
| Mar 2000 | - | $11.81 M | $11.81 M |
| Dec 1999 | $39.77 M(+16.5%) | - | - |
| Dec 1998 | $34.14 M | - | - |
FAQ
- What is Charles River Laboratories International annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Charles River Laboratories International?
- What is Charles River Laboratories International annual SG&A year-on-year change?
- What is Charles River Laboratories International quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly SG&A year-on-year change?
- What is Charles River Laboratories International TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Charles River Laboratories International?
- What is Charles River Laboratories International TTM SG&A year-on-year change?
What is Charles River Laboratories International annual selling, general & administrative expenses?
The current annual SG&A of CRL is $747.86 M
What is the all time high annual SG&A for Charles River Laboratories International?
Charles River Laboratories International all-time high annual selling, general & administrative expenses is $747.86 M
What is Charles River Laboratories International annual SG&A year-on-year change?
Over the past year, CRL annual selling, general & administrative expenses has changed by +$82.76 M (+12.44%)
What is Charles River Laboratories International quarterly selling, general & administrative expenses?
The current quarterly SG&A of CRL is $199.21 M
What is the all time high quarterly SG&A for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly selling, general & administrative expenses is $199.76 M
What is Charles River Laboratories International quarterly SG&A year-on-year change?
Over the past year, CRL quarterly selling, general & administrative expenses has changed by +$2.07 M (+1.05%)
What is Charles River Laboratories International TTM selling, general & administrative expenses?
The current TTM SG&A of CRL is $8.02 B
What is the all time high TTM SG&A for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM selling, general & administrative expenses is $759.30 M
What is Charles River Laboratories International TTM SG&A year-on-year change?
Over the past year, CRL TTM selling, general & administrative expenses has changed by +$7.28 B (+972.85%)